KELSEY WEIR: Open Payments
NPI 1548856248 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 86 payments from 21 companies in 2025. Trend: 2023 $158 · 2024 $209 · 2025 $1,620
Food & beverage: $1,620
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $443 |
| PFIZER INC. | 17 | $306 |
| UCB, Inc. | 4 | $123 |
| Neurocrine BioSciences, Inc. | 3 | $115 |
| Lundbeck LLC | 3 | $82 |
| ARGENX US, INC. | 3 | $74 |
| ACADIA Pharmaceuticals Inc | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Eisai Inc. | 2 | $50 |
| Amneal Pharmaceuticals LLC | 2 | $37 |
Products named: QULIPTA, NURTEC ODT, INGREZZA, VYEPTI, UBRELVY, NUPLAZID, Nayzilam, KESIMPTA.
Industry payments across GA — which companies pay providers there.
